Careium AB (publ)
STO:CARE

Watchlist Manager

Careium AB (publ)

STO:CARE

Watchlist

Price: 32.8 SEK -1.5% Market Closed

Market Cap: 797.9m SEK

Have any thoughts about
Careium AB (publ)?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	Abbvie Inc NYSE:ABBV	Biotechnology
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Realty Income Corp NYSE:O	Real Estate
US	Walt Disney Co NYSE:DIS	Media
US	PayPal Holdings Inc NASDAQ:PYPL	Technology

Add Price Alert

Price Target:

Last Price: 32.8 SEK

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

CARE Alert

Careium AB (publ)

32.8

-0.5 (-1.5%)

52 Week Range	15.3 36.6
Price Target

We'll email you a reminder when the closing price reaches SEK.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	Abbvie Inc NYSE:ABBV	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Realty Income Corp NYSE:O	US
	Walt Disney Co NYSE:DIS	US
	PayPal Holdings Inc NASDAQ:PYPL	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Careium AB (publ)

What unique competitive advantages
does Careium AB (publ) hold over its rivals?

What risks and challenges
does Careium AB (publ) face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Careium AB (publ).

What unique competitive advantages
does Careium AB (publ) hold over its rivals?

What risks and challenges
does Careium AB (publ) face in the near future?

Summarize the latest earnings call
of Careium AB (publ).

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Careium AB (publ).

Provide P/S
for Careium AB (publ).

Provide P/E
for Careium AB (publ).

Provide P/OCF
for Careium AB (publ).

Provide P/FCFE
for Careium AB (publ).

Provide P/B
for Careium AB (publ).

Provide EV/S
for Careium AB (publ).

Provide EV/GP
for Careium AB (publ).

Provide EV/EBITDA
for Careium AB (publ).

Provide EV/EBIT
for Careium AB (publ).

Provide EV/OCF
for Careium AB (publ).

Provide EV/FCFF
for Careium AB (publ).

Provide EV/IC
for Careium AB (publ).

Show me price targets
for Careium AB (publ) made by professional analysts.

What are the Revenue projections
for Careium AB (publ)?

How accurate were the past Revenue estimates
for Careium AB (publ)?

What are the Net Income projections
for Careium AB (publ)?

How accurate were the past Net Income estimates
for Careium AB (publ)?

What are the EPS projections
for Careium AB (publ)?

How accurate were the past EPS estimates
for Careium AB (publ)?

What are the EBIT projections
for Careium AB (publ)?

How accurate were the past EBIT estimates
for Careium AB (publ)?

Compare the revenue forecasts
for Careium AB (publ) with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Careium AB (publ) and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Careium AB (publ) against its competitors.

Analyze the profit margins
(gross, operating, and net) of Careium AB (publ) compared to its peers.

Compare the P/E ratios
of Careium AB (publ) against its peers.

Discuss the investment returns and shareholder value creation
comparing Careium AB (publ) with its peers.

Analyze the financial leverage
of Careium AB (publ) compared to its main competitors.

Show all profitability ratios
for Careium AB (publ).

Provide ROE
for Careium AB (publ).

Provide ROA
for Careium AB (publ).

Provide ROIC
for Careium AB (publ).

Provide ROCE
for Careium AB (publ).

Provide Gross Margin
for Careium AB (publ).

Provide Operating Margin
for Careium AB (publ).

Provide Net Margin
for Careium AB (publ).

Provide FCF Margin
for Careium AB (publ).

Show all solvency ratios
for Careium AB (publ).

Provide D/E Ratio
for Careium AB (publ).

Provide D/A Ratio
for Careium AB (publ).

Provide Interest Coverage Ratio
for Careium AB (publ).

Provide Altman Z-Score Ratio
for Careium AB (publ).

Provide Quick Ratio
for Careium AB (publ).

Provide Current Ratio
for Careium AB (publ).

Provide Cash Ratio
for Careium AB (publ).

What is the historical Revenue growth
over the last 5 years for Careium AB (publ)?

What is the historical Net Income growth
over the last 5 years for Careium AB (publ)?

What is the current Free Cash Flow
of Careium AB (publ)?

Discuss the annual earnings per share (EPS)
trend over the past five years for Careium AB (publ).

EV/EBITDA
Enterprise Value to EBITDA

Current

3.8

Median

12.5

Industry

Higher than median

Lower than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA

Enterprise Value

763.1m SEK

EBITDA

152.1m SEK

All Countries

Forward Multiples

			Market Cap	EV/EBITDA
SE	C	Careium AB (publ) STO:CARE	797.9m SEK	5
US		Abbott Laboratories NYSE:ABT	198.6B USD	20.5
US		Intuitive Surgical Inc NASDAQ:ISRG	174.1B USD	69
US		Stryker Corp NYSE:SYK	139.1B USD	26
US		Boston Scientific Corp NYSE:BSX	123.1B USD	32.6
IE		Medtronic PLC NYSE:MDT	114.7B USD	15.2
US		Becton Dickinson and Co NYSE:BDX	67.8B USD	15.4
DE		Siemens Healthineers AG XETRA:SHL	55.5B EUR	17.1
US		IDEXX Laboratories Inc NASDAQ:IDXX	42.6B USD	35.7
US		GE Healthcare Technologies Inc NASDAQ:GEHC	41.4B USD	15.6
US		Edwards Lifesciences Corp NYSE:EW	40.5B USD	21.6

				EBITDA Growth
SE	C	Careium AB (publ) STO:CARE	Average EV/EBITDA: 24.9 5	33%
US		Abbott Laboratories NYSE:ABT	20.5	32%
US		Intuitive Surgical Inc NASDAQ:ISRG	69	106%
US		Stryker Corp NYSE:SYK	26	39%
US		Boston Scientific Corp NYSE:BSX	32.6	69%
IE		Medtronic PLC NYSE:MDT	15.2	29%
US		Becton Dickinson and Co NYSE:BDX	15.4	35%
DE		Siemens Healthineers AG XETRA:SHL	17.1	61%
US		IDEXX Laboratories Inc NASDAQ:IDXX	35.7	38%
US		GE Healthcare Technologies Inc NASDAQ:GEHC	15.6	41%
US		Edwards Lifesciences Corp NYSE:EW	21.6	28%

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward

EV/EBITDA

2-Years Forward

EV/EBITDA

4.5

3-Years Forward

EV/EBITDA

4.2

Careium AB (publ)
STO:CARE

EV/EBITDA
Enterprise Value to EBITDA

EV/EBITDA Forward Multiples

See Also

Company

Help

Tools

Stocks

Careium AB (publ) STO:CARE

EV/EBITDA Enterprise Value to EBITDA

EV/EBITDA Forward Multiples

See Also

Company

Help

Tools

Stocks

Careium AB (publ)
STO:CARE

EV/EBITDA
Enterprise Value to EBITDA